Asset
Licaminlimab
Oculis Holding AG Ordinary shares
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07548632 | phase2_3 | recruiting | 2026-04-16 | 2026-12-01 | Oculis | A Clinical Study Evaluating Licaminlimab for Dry Eye Disease |
| NCT05896670 | phase2 | completed | 2023-11-29 | 2024-03-27 | Oculis | Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease |
FDA applications (0)
This company has no applications containing this asset.